Lacosamide Tablets — Class II drug recall D-0626-2026
Ongoing recall by Annora Pharma Private Limited, reported 2026-07-01, distributed nationwide. Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of
| Recall number | D-0626-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Annora Pharma Private Limited, Hyderabad, N/A, India |
| Recall initiated | 2026-06-04 |
| Classified | 2026-06-25 |
| Reported by FDA | 2026-07-01 |
| Distributed | Nationwide (US) |
| NDC | 31722-0812, 31722-0812-05, 31722-0812-18, 31722-0812-32, 31722-0812-60, 31722-0813, 31722-0813-05, 31722-0813-18, 31722-0813-32, 31722-0813-60, 31722-0814, 31722-0814-05, 31722-0814-18, 31722-0814-32, 31722-0814-60, 31722-0815, 31722-0815-05, 31722-0815-18, 31722-0815-32, 31722-0815-60 |
| Lot numbers | A253999, A254000 |
| Expiration dates | 2027-09-30 |
Product
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
Reason for recall
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0626-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.